Skip to content
10-Q

Quarterly Report

QLY BIOTECH GROUP CORP.

0001477932-23-000247

← back to feed
Filed
Jan 13, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Jan 13, 2023 3.9M sh
Operating Cash Flow Q1 2023 · Nov 30, 2022 −$5.67K
Operating Cash Flow Q1 2023 · Nov 30, 2021 −$4.81K
Stockholders Equity Q1 2023 · Nov 30, 2022 −$8.05K
Stockholders Equity Q1 2023 · Aug 31, 2022 $0
Stockholders Equity Q1 2023 · Nov 30, 2021 −$10.18K
Stockholders Equity Q1 2023 · Aug 31, 2021 −$5.96K
Current Liabilities Q1 2023 · Nov 30, 2022 $8.05K
Current Liabilities Q1 2023 · Aug 31, 2022 $0
Total Liabilities Q1 2023 · Nov 30, 2022 $8.05K
Total Liabilities Q1 2023 · Aug 31, 2022 $0
Total Assets Q1 2023 · Nov 30, 2022 $0
Total Assets Q1 2023 · Aug 31, 2022 $0
Sga Expense Q1 2023 · Nov 30, 2022 $9.17K
Sga Expense Q1 2023 · Nov 30, 2021 $4.21K
Net Income Q1 2023 · Nov 30, 2022 −$9.17K
Net Income Q1 2023 · Nov 30, 2021 −$4.21K
Gross Profit Q1 2023 · Nov 30, 2022 $0
Gross Profit Q1 2023 · Nov 30, 2021 $0
Cost Of Revenue Q1 2023 · Nov 30, 2022 $0
Cost Of Revenue Q1 2023 · Nov 30, 2021 $0
Revenue Q1 2023 · Nov 30, 2022 $0
Revenue Q1 2023 · Nov 30, 2021 $0